IRIS
ABIGNENTE DI FRASSELLO, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 880
NA - Nord America 569
AS - Asia 116
AF - Africa 10
Totale 1.575
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 547
DE - Germania 475
UA - Ucraina 161
IT - Italia 107
CN - Cina 92
NL - Olanda 57
FI - Finlandia 34
CA - Canada 21
TR - Turchia 14
SE - Svezia 13
CI - Costa d'Avorio 10
GB - Regno Unito 10
FR - Francia 9
IE - Irlanda 7
RU - Federazione Russa 5
VN - Vietnam 4
IN - India 3
SA - Arabia Saudita 2
BE - Belgio 1
HU - Ungheria 1
MX - Messico 1
SG - Singapore 1
Totale 1.575
Salva come PNG Salva come JPEG
Città #
Chandler 147
Jacksonville 104
Amsterdam 56
Princeton 33
Naples 30
Beijing 28
Millbury 20
Ottawa 19
Wilmington 18
Nanjing 17
Boston 15
Nanchang 12
Hebei 11
Dublin 5
Houston 5
Norwalk 5
Ashburn 4
Changsha 4
Dong Ket 4
Falls Church 4
Jiaxing 4
Kronberg 4
Napoli 4
Paris 4
Shenyang 4
Siena 4
Boardman 3
Kunming 3
Pomigliano D'arco 3
Varedo 3
Andover 2
Changchun 2
Dearborn 2
Frankfurt am Main 2
Gatchina 2
Makkah 2
Rende 2
Salò 2
Siracusa 2
Stilo 2
Budapest 1
Castellammare Di Stabia 1
Clearwater 1
Fairfield 1
Fisciano 1
Fuzhou 1
Giugliano In Campania 1
Guangzhou 1
Hanover 1
Helsinki 1
Lanzhou 1
Leuven 1
Melito di Napoli 1
Milan 1
Monza 1
Moscow 1
Ningbo 1
Nocera Superiore 1
Padova 1
Pomigliano d'Arco 1
Pozzuoli 1
Redmond 1
Reggio Calabria 1
Rimini 1
San Mateo 1
Seattle 1
Shanghai 1
Sherbrooke 1
St Petersburg 1
Stella Cilento 1
Stockholm 1
Toronto 1
Vijayawada 1
Woodbridge 1
Totale 631
Salva come PNG Salva come JPEG
Nome #
2-fenil-imidazo[1,2-B]piridazine ad attività analgesica ed antiepilettica 129
Derivati glicosilati della Nω-Nitro-L-Arginina come agenti antitumorali 100
Profarmaco galattosilato del ketorolac ad uso analgesico e antinfiammatorio con migliori caratteristiche farmacocinetiche e profilo tossicologico del farmaco di partenza 95
Composizioni farmaceutiche a base di zeoliti porose quali mezzi di rilascio di molecole farmacologicamente attive e relativo uso 61
Design, synthesis and biological evaluation of novel N-alkyl- and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs) as novel A1 adenosine receptor antagonists 55
New Fluorescent 2-Phenylindolglyoxylamide Derivatives as Probes Targeting the Peripheral-Type Benzodiazepine Receptor: Design, Synthesis and Biological Evaluation. 52
Galactosylated dopamine enters into the brain, blocks mesocorticolimbic system and modulates activity and scanning time in naples high excitability rats 51
N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of Potent and Selective Ligands at the Peripheral Benzodiazepine Receptor. 51
Synthetic Zeolites as a New Tool for Drug Delivery 49
Galactosyl Derivative of N(omega)-Nitro-L-Arginine: Study of Antiproliferative Activity on Human Thyroid Follicular Carcinoma Cells 49
Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery 48
New synthetic method for 4-hydroxyproline 48
Research on heterocyclic compounds. Part XXXVI. Imidazo[1,2-a]pyrimidine-2-acetic derivatives: synthesis and antiinflammatory activity 45
Pharmaceutical compositions based on porous zeolites as release means of pharmacologically active molecules and relative use 45
Imidazo[1,2-b]pyridazines: studies on chemical structure antiinflammatory activity relationships. 45
Profarmaco galattosilato della N-omega-nitro-L-arginina (nagal) ad uso analgesico ed antinfiammatorio con migliore caratteristiche farmacocinetiche e di tollerabilità del farmaco di partenza 43
Research on heterocyclic compounds - Part XXXIX. 2-Methylimidazo[1,2-a]pyrimidine-3-carboxylic derivatives: Synthesis and antiinflammatory activity 42
Principi di analisi quantitativa dei medicinali 42
Research on heterocyclic compounds, part 40. 2-phenylimidazo[1,2-a]pyridine-3-carboxilic acid derivatives: synthesis and antiinflammatory activity. 41
Research on heterocyclic compounds, xxix. Synthesis and antiinflammatory activity of imidazo[1,2-a]pyrazine derivatives. 41
Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect 41
Research on heterocyclic compounds. XXXVII. Synthesis and antiinflammatory activity of methyl-substituted imidazo[1,2-a]pyrazine derivatives 40
Synthesis and structure-activity relationships of a series of analgesic imidazo[1,2-b]pyridazine acidic derivatives 39
Research on heterocyclic compounds, xxxi. Synthesis and antiinflammatory activity of 2-arylimidazo[1,2-a]pyrazine-3-carboxylic acids. 39
Research on heterocyclic compounds. XLI. 2-Phenylimidazo[1,2-b]pyridazine-3-acetic derivatives: synthesis and anti-inflammatory activity 38
Synthesis and in vitro chemical and enzymatic stability of glycosyl 3'-azido-3'-deoxythymidine derivatives as potential anti-HIV agents 37
Research on heterocyclic compounds. XXXIV. Synthesis and SAR study of some imidazo[2,1-b]thiazole carboxylic and acetic acids with antiinflammatory and analgesic activities 37
Research on heterocyclic compounds. XLII. The Vilsmeier reaction in the synthesis of imidazo[1,2-a]pyrimidine derivatives 36
Research on heterocyclic compounds. XXXV. Synthesis of 2-phenylimidazo[1,2-a]pyrazine-3-acetates 36
Research on heterocyclic compounds. XL. 2-Phenylimidazo[1,2-a]pyridine-3-carboxylic acid derivatives: synthesis and antiinflammatory activity 35
Research on heterocyclic compounds. xxxvii. synthesis and antiinflammatory activity of methyl-substituted imidazo[1,2-a]pyrazine derivatives 35
Research on heterocyclic compounds, xxxv [1]. Synthesis of 2-phenylimidazo[1,2-a]pyrazine-3-acetates. 34
RESEARCH ON HETEROCYCLIC COMPOUNDS. XLIII. SYNTHETIC STUDIES ON 1,4-DIHYDROPYRIDINE DERIVATIVES. 21
Totale 1.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 2 2
2019/2020165 35 9 18 0 22 0 4 0 4 16 23 34
2020/2021263 7 27 56 26 27 29 27 3 23 3 27 8
2021/2022132 3 7 4 5 0 1 2 5 3 5 48 49
2022/2023340 37 38 10 31 40 25 8 29 54 57 10 1
2023/2024114 11 30 37 3 4 6 1 17 0 5 0 0
Totale 1.600